𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients

✍ Scribed by Anders Lundqvist; Adiba Isa; Thomas Tolfvenstam; Göran Kvist; Kristina Broliden

Book ID
116630772
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
64 KB
Volume
33
Category
Article
ISSN
1386-6532

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evidence for persistence of human parvov
Evidence for persistence of human parvovirus B19 DNA in bone marrow
✍ Cassinotti, P.; Burtonboy, G.; Fopp, M.; Siegl, G. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB 👁 2 views

A nested polymerase chain reaction assay (nPCR) was used to investigate the potential of human parvovirus B19 DNA to persist in blood or bone marrow samples obtained either from blood donors or cadaveric bone donors or from patients presenting with clinical signs of parvovirus B19 infection. The pre

Presence and significance of human parvo
Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin
✍ Cassinotti, P.; Siegl, G.; Michel, B. A.; Brühlmann, P. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

Acute rheumatologic symptoms are frequently associated with human parvovirus B19 (B19) infections. A nested PCR (nPCR) assay was used to test for the presence of parvovirus B19 DNA in synovial fluid and/or synovial membrane specimens obtained from a total of 90 patients with arthritis of unknown ori

High-resolution analysis of acquired gen
High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes
✍ Alistair G. Reid; Patrick S. Tarpey; Ellie P. Nacheva 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 520 KB

## Abstract Chronic myeloid leukemia (CML) is a biphasic hematopoietic malignancy associated with a single cytogenetic aberration, the Philadelphia translocation t(9;22)(q34;q11), resulting in the __BCR‐ABL1__ fusion oncogene. Molecular heterogeneity was recently demonstrated in the form of extensi